Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment
<p class="p p-first-last" id="__p2">After rifampin and levofloxacin treatment for a <em>Staphylococcus aureus</em> bone infection, a pyogenic granuloma due to a newly described <em>Cutibacterium</em> species,<em> C. namnetense</em> develo...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Copernicus Publications
2018-11-01
|
| Series: | Journal of Bone and Joint Infection |
| Online Access: | https://jbji.copernicus.org/articles/3/255/2018/jbji-3-255-2018.pdf |
| Summary: | <p class="p p-first-last" id="__p2">After rifampin and levofloxacin treatment for a <em>Staphylococcus aureus</em> bone infection, a pyogenic granuloma due to a newly described <em>Cutibacterium</em> species,<em> C. namnetense</em> developed on the tibia former external fixator. This rifampin resistant bacterium, selected during treatment, harbored a mutation in the <em>rpoB</em> gene. This case illustrates the possible <em>in vivo</em> selection of resistant mutant most likely due to the bacterial burden and therefore the importance of adequate bone infection treatment.</p> |
|---|---|
| ISSN: | 2206-3552 |